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Abstract
Background—Peri-coronary epicardial adipose tissue (cEAT) serves as a metabolic and 
paracrine organ that contributes to inflammation and is associated with macrovascular coronary 
artery disease (CAD) development. While there is a strong correlation in humans between cEAT 
volume and CAD severity, there remains a paucity of experimental data demonstrating a causal 
link of cEAT to CAD. The current study tested the hypothesis that surgical resection of cEAT 
attenuates inflammation and CAD progression.
Methods—Female Ossabaw miniature swine (n=12) were fed an atherogenic diet for 8 months 
and randomized into sham (n=5) or adipectomy (n=7) groups. Both groups underwent a 
thoracotomy, opening of the pericardial sac, and placement of radio-opaque clips to mark the 
proximal left anterior descending artery. Adipectomy swine underwent removal of 1–1.5 cm2 of 
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cEAT from the proximal artery. Following sham or adipectomy, CAD severity was assessed with 
intravascular ultrasound. Swine recovered for an additional 3 months on atherogenic diet and CAD 
was assessed immediately prior to euthanasia. Artery sections were processed for histological and 
immunohistochemical analysis.
Results—CAD severity, as assessed by percent stenosis, was reduced in the adipectomy cohort 
compared to shams; however, plaque size remained unaltered, while sham-operated swine 
developed greater plaque sizes. Adipectomy resulted in an expanded arterial diameter, similar to 
the Glagov phenomenon of positive outward remodeling. No differences in inflammatory marker 
expression were observed.
Conclusions—These data indicate that cEAT resection did not alter inflammatory marker 
expression, but arrested CAD progression through increased positive outward remodeling and 
arrest of atherogenesis.
Classifications
Atherosclerosis; Coronary Artery Disease; Coronary Artery Imaging; Inflammatory Mediators; 
Obesity
Coronary epicardial adipose tissue (cEAT) is an adipose tissue depot located on the surface 
of the heart, encasing and interacting with the epicardial coronary arteries. Mounting 
evidence that cEAT serves as a metabolic and paracrine organ (1) provides an impetus for 
growing interest in cEAT as a causal factor in coronary artery disease (CAD) etiology. cEAT 
thickness and volume directly correlate with CAD severity in humans (1–10).
Metabolic syndrome (MetS), defined as the clustering of three of the following five risk 
factors: central obesity, hypertension, dyslipidemia, glucose intolerance, and insulin 
resistance, doubles the risk of developing CAD (11, 12). cEAT volume is increased in MetS 
(13–16), and the inflammatory adipokine profile is altered in cEAT during MetS and CAD 
(16–18). Thus, one of the mechanisms whereby MetS exacerbates CAD may be through 
effects of cEAT on the coronary vasculature.
Many human studies conducted on the link between cEAT and CAD development have been 
observational, showing a positive correlation between cEAT volume and CAD severity (2–
7). There remains a need for experimental animal studies to determine a causal role of cEAT 
in CAD progression (16). To this end, we have developed an animal model, the Ossabaw 
miniature swine, which naturally recapitulates human components of MetS and CAD (19, 
20). We previously examined the effect of cEAT removal from the middle segment of the left 
anterior descending coronary artery (LAD) in Ossabaw swine using an intra-artery control, 
demonstrating that CAD progression was attenuated in the surgical region, compared to 
adjacent regions (21). However, in the absence of sham-operated controls, questions 
remained regarding the control of surgery-induced inflammation, the robustness of the 
observations, and the nature of CAD attenuation. Reductions in coronary luminal 
encroachment may be explained by one of two vascular remodeling scenarios: 1) reductions 
in or curtailment of plaque size, or 2) enhancement of compensatory expansion of the 
coronary arterial wall, such as that classically described by Glagov, et al (22). Accordingly, 
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we performed a sham-controlled study to test the hypothesis that cEAT removal attenuates 
CAD and is associated with outward vascular remodeling.
Material and Methods
Animal care and use
This protocol was approved by the Indiana University School of Medicine Animal Care and 
Use Committee and conducted in accordance with the Guide for the Care and Use of 
Laboratory Animals (23). Female Ossabaw miniature swine (n=12) were fed an excess-
calorie, atherogenic diet for a total of 11 months (KT-324, Purina Test Diet, Richmond, IN; 
16.3% kcal from protein, 40.8% kcal from complex carbohydrates, 19% kcal from fructose, 
and 42.9% kcal from fat; 1 kg once daily) supplemented with cholesterol (2.0%), 
hydrogenated coconut oil (4.70%), hydrogenated soybean oil (8.40%), cholate (0.70%), and 
high fructose corn syrup (5.0%) by weight, and consequently developed MetS and CAD, as 
previously described (20, 24, 25). All pigs were individually housed with a 12 hour light/
dark cycle and free access to drinking water. Metabolic data were collected to confirm MetS 
and to identify any potential variables between the experimental and control groups (Table 
1). After 8 months on diet, pigs were randomized to either an adipectomy (cEATx; n=7) or 
sham (n=5) group.
Anesthesia
After an overnight fast, anesthesia was induced with intramuscular administration of telazol 
(4.5–5.5 mg/kg) and xylazine (2.2 mg/kg). Following intubation, anesthesia was maintained 
with 2–4% isoflurane and 100% O2. Isoflurane levels were adjusted to maintain appropriate 
heart rate, blood pressure, respiratory rate, and cardiac electrical activity throughout the 
procedure.
Adipectomy
Following local anesthesia with lidocaine, a left-sided thoracotomy was performed and the 
lung was retracted to expose the heart. An incision was made in the pericardial sac above the 
region of the proximal LAD. Approximately 1–1.5 cm2 of cEAT was excised from the 
proximal LAD and radio-opaque ligation clips were placed around the surgical site. These 
clips confirmed the interrogated tissue upon euthanasia and tissue collection (Figure 1). 
Sham pigs also underwent a thoracotomy, opening of the pericardial sac, and placement of 
the ligation clips in efforts to control variables between groups.
Intravascular Ultrasound imaging
Following the adipectomy or sham procedure, intravascular ultrasound (IVUS) imaging was 
conducted in the left anterior descending (LAD) as previously described (20, 21, 25), using a 
45 MHz IVUS catheter (Volcano Corp., Rancho Cordova, CA). IVUS was repeated 3 
months post-adipectomy prior to euthanasia.
IVUS analysis was performed by a single observer blinded to experimental group and time 
point. Location within each artery was determined by identification of the left main coronary 
artery bifurcation and IVUS still-frames were analyzed in the proximal 15 mm of the LAD 
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utilizing ImageJ (NIH) software as previously described (19, 26, 27). External elastic lamina 
(EEL) cross-sectional area is indicated with a red dashed line in Figure 2A. Lumen cross-
sectional area is indicated with the yellow dotted line in Figure 2A. Percent stenosis 
quantifies the percentage of the area within the EEL that is occupied by atherosclerotic 
plaque, using the formula (EEL area – lumen area)/EEL area*100%. We assessed percent 
stenosis progression with the equation Percent StenosisSacrifice – Percent StenosisSurvivaL 
Outward remodeling was assessed by examining the change in EEL area from survival to 
sacrifice. Unadjusted plaque area at survival surgery and at sacrifice was assessed with the 
following formula: EEL area – lumen area.
Histology and immunohistochemistry
Specimens were collected from the healed surgical site of adipectomy pigs and from the 
corresponding region of the LAD of sham pigs, identified with clips placed in cEAT during 
survival surgery. The surrounding myocardium, adventitia, and adipose tissue were left 
intact, the specimen was fixed in 10% phosphate-buffered formalin for 24–48 hours, 
transferred to 70% ethanol, and embedded in paraffin. The Verhoeff-Van Gieson stain 
positively identified the elastic laminae (Figure 2A: far right images), allowing us to 
quantify percent stenosis. The results were compared between experimental and sham 
groups as well as with the IVUS percent stenosis data to confirm our in vivo technique. 
Immunohistochemistry was performed by the pathology core at Indiana University School of 
Medicine. Cell proliferation was quantified by positive Ki-67 staining of cells within the 
intima and expressed as a percentage of total cell count. Inflammation was assessed with 
macrophage scavenger receptor-A (1:100 dilution, Cosmo Bio USA, Inc. #KAL-KT022) and 
T-cadherin (1:1000 dilution, Abgent #CDH13, AP14346) as previously described (21) and 
expressed as a percentage of total area.
Statistics
Data are described as mean ± standard error. Statistical significance was set at p<0.05. 
Paired, one-tailed Student’s t-tests and unpaired one-tailed Student’s t-tests were conducted 
where appropriate using PRISM software (GraphPad Software Inc., La Jolla, CA).
Results
Metabolic data
All pigs continuously gained weight throughout the study and upon sacrifice there was no 
difference in body weights across groups. Assessment of total cholesterol, triglycerides, 
fasting blood glucose, and blood pressures revealed no metabolic differences between sham 
and cEATx pigs at euthanasia (Table 1).
Percent stenosis
Change in percent stenosis over the 3 month recovery period was significantly higher in the 
proximal LAD of sham pigs compared to cEATx (Figure 2B). Sham pigs displayed a 
positive change in percent stenosis, while a negative change in percent stenosis was seen in 
cEATx pigs.
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The validity of our in vivo IVUS assessment of percent stenosis was confirmed by its 
significant correlation (r = 0.85) with histological measure of percent stenosis (Figure 2C).
Cell proliferation and plaque area
To investigate the apparent plaque regression of cEATx pigs, intimai Ki-67 positive cells 
were quantified. LAD segments from sham pigs demonstrated significantly more 
proliferating cells compared to cEATx pigs; however, both groups revealed evidence of cell 
proliferation (Figure 3 A–C).
To directly assess changes in plaque size independent of vessel diameter, the unadjusted area 
of the plaque was examined. Plaque area in sham pigs significantly increased in size over the 
3 month recovery period, while size of plaque in the analogous LAD segment of cEATx pigs 
was unchanged (Figure 3D).
Inflammatory marker expression
Expression of macrophage scavenger receptor A and T-cadherin were examined within 
atherosclerotic plaques and in surrounding adipose tissue. Removal of cEAT did not alter 
inflammatory marker expression in either region (Figure 4).
Outward remodeling
At euthanasia, cEATx pigs demonstrated a greater EEL area as assessed with IVUS, 
compared to shams (Figure 5A). To determine whether this increase in EEL area was 
compensatory outward remodeling, we examined the correlation between EEL and plaque 
size at both survival and sacrifice. At survival, there was no difference between this 
correlation across groups (Figure 5B). However, at the time of sacrifice (3 months after the 
procedure), cEATx pigs demonstrated a significantly more positive correlation compared to 
sham pigs (Figure 5C). The slopes of the regression lines are graphically represented in 
Figure 5D. In sham-operated controls, correlation of arterial expansion (change in EEL area) 
with plaque growth is reduced at sacrifice, compared to survival surgery. However, in 
cEATx-operated swine, arterial expansion during plaque growth was maintained from 
survival to sacrifice.
As a final measure of the effect of compensatory outward remodeling, the lumen area was 
compared across groups and time points. At the site of surgical intervention, the lumen area 
in cEATx pigs significantly increased from survival to sacrifice, but was unaltered in sham 
pigs (Figure 6).
Comment
We examined the effect of surgical removal of cEAT on CAD progression in vivo. We 
confirm that selective segmental cEAT resection in Ossabaw swine with MetS arrests 
atherogenesis, measured by percent stenosis (Fig 2). The measure of percent stenosis 
assesses plaque size as a function of external elastic lamina area. Thus, to determine whether 
the decreased percent stenosis associated with the cEATx cohort was due to reduction in 
plaque size or to other factors, we examined plaque cell proliferation and plaque size. 
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Plaques in the cEATx group displayed less plaque cell proliferation, compared to sham-
operated controls (Fig 3C). Plaque size increased in sham animals, but remained unchanged 
in cEATx animals (Fig 3D). Thus, we concluded that the reduced percent stenosis observed 
in the cEATx cohort was not due to plaque regression.
The arrest of atherogenesis is associated with expansion of the coronary segment lacking 
overlying cEAT (Fig 4C). This enlargement of coronary arterial lumen is reminiscent of the 
Glagov phenomenon (22). Fig 6B–C summarizes our findings, demonstrating that a Glagov-
like phenomenon without plaque regression, is responsible for the luminal expansion 
observed in the cEATx cohort.
Hypothetically, cEAT might act as a scaffold, tethering the coronary artery to the epicardial 
surface and limiting movement during the cardiac cycle. The contiguity of cEAT with 
coronary arterial adventitia without an intervening fibrous layer (2, 8, 17, 28) might also 
restrict outward dilation of the proximal conduit coronary artery during diastole. 
Alternatively, cEAT from obese Ossabaw pigs expresses and secretes vasoconstrictors (29–
31) which when removed might result in tonic vasodilation. It cannot be determined from 
our work whether the expansion of the EEL is due to outward medial enlargement or to 
enhanced vasodilation.
Molecular mechanisms for the arrest of atherogenesis have not been elucidated in our study. 
It is established that cEAT overlying atheromatous plaques contains dense numbers of 
inflammatory macrophages and lymphocytes and secretes pro-atherogenic cytokines (18, 
32–37). Adipectomy might remove inflammatory cells and cytokines (21), thereby halting 
migration from outside the adventitia into the intima-media and reducing plaque expansion. 
However, we did not find any difference in some markers of atherogenesis in both the intima 
and cEAT layers of the adipectomised versus sham LAD segment. This suggests the removal 
of outside-to-inside paracrine factors less likely accounted for the beneficial anti-
atherosclerotic effect; however, because of the limited number of inflammatory factors 
interrogated, it does not rule out a paracrine/vasocrine effect of cEAT on atherogenesis. 
Future studies should undertake a comprehensive examination of inflammatory gene 
expression to further elucidate an underlying mechanism for the role of cEAT in promoting 
atherogenesis. These paracrine/vasocrine factors should be distinguished from the role of 
cEAT vs. myocardium in mechanically compressing the coronary artery and restricting 
outward remodeling (38). Wall shear stress is important in enhancing endothelial function 
and halting atherogenesis (39, 40). Although we have no direct evidence, there is the 
possibility that in the cEATx vessel, shear stress was modified by luminal expansion. In our 
previous study (21), the manipulated LAD segment showed immunohistochemical evidence 
of less inflammation compared to the distal and proximal sections of the same LAD. The 
reasons for this lack of concordance between our prior and this current study are unclear, but 
a likely explanation is that the level of overall inflammatory marker expression was higher in 
the current study because the surgical sham group was included. Another possibility is a 
different effect of gender on the inflammatory response, since our previous study was on 
castrated males vs. females in this study.
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Our current findings address the consideration raised in our earlier study (21) that cEAT 
adipectomy at the time of coronary artery bypass grafting might be used as adjunctive 
treatment to reduce the progression of atheroma post-grafting. Clearly, our results only apply 
to an early phase in the natural history of CAD without clinically significant luminal 
stenoses. In contrast, patients undergoing bypass grafting present with late stages of CAD 
who have substantial, flow-limiting stenoses (41). It will be of interest to investigate whether 
lifestyle modifications such as weight loss will result in similar cEAT mass/volume 
reduction, as this would be a safer and more appropriate strategy than invasive adipectomy.
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Figure 1. Protocol for removal of coronary epicardial adipose tissue
A) Diagram of coronary arteries depicting region of cEAT removal. B) Following removal of 
cEAT, radio-opaque ligation clips (black arrows) were placed near the surgery site. C) 
Representative coronary angiogram obtained following the adipectomy procedure. Radio-
opaque ligation clips are visible markers of the adipectomy / sham site (black arrows). D) 
Following euthanasia, adipectomy site was identified by location of ligation clips (black 
arrow). CFX = Circumflex artery; LAD = Left anterior descending coronary artery; RCA = 
Right coronary artery; LM = left main coronary artery; LV = Left ventricle.
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Figure 2. Removal of coronary epicardial adipose tissue attenuates coronary artery disease 
progression
A) Representative IVUS still frames at survival surgery (8 mos) and euthanasia (11 mos). 
IVUS was verified with Verhoeff-Van Gieson histology. Red dashed line = external elastic 
lamina; Yellow dotted line = lumen; white dots are placed 1 mm apart. B) Removal of cEAT 
significantly attenuates CAD progression, as assessed by percent stenosis (p < 0.05). C) 
IVUS measurement of percent stenosis correlates with histological measurement of percent 
stenosis, verifying IVUS assessment of CAD severity.
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Figure 3. Coronary epicardial adipose tissue removal does not alter plaque size, but attenuates 
intimal cell proliferation
A) Representative sham-operated intimal section stained with Ki-67. Black arrows indicate 
positive staining. B) Representative cEATx intimal section stained with Ki-67. Black arrows 
indicate positive staining. C) Intimal cell proliferation reduced in cEATx arteries, compared 
to shams (p < 0.05). D) Plaque area significantly increased following survival procedure in 
sham-operated animals (p < 0.05), but was unchanged in cEATx swine (p = 0.2).
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Figure 4. Expression of inflammatory markers is unaltered by removal of epicardial adipose 
tissue
A–H) Representative images of macrophage scavenger receptor-A (MSR-A) and t-cadherin 
stained arterial (A,C,E,G) and adipose (B,D,F,H) sections from sham-operated (A–D) and 
cEATx-operated (E–H) swine. I) MSR-A expression within atherosclerotic plaques is 
unchanged by cEATx operation J) MSR-A expression within adipose tissue is unchanged by 
cEATx operation. K) T-cadherin expression within atherosclerotic plaques is unchanged by 
cEATx operation. L) T-cadherin expression within adipose tissue is unchanged by cEATx 
operation.
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Figure 5. The Glagov phenomenon is potentiated with coronary epicardial adipose tissue 
resection
A – B) Removal of cEAT shifts the relationship between external elastic lamina (EEL) area 
and plaque area, thus potentiating outward remodeling during plaque growth. C) Outward 
remodeling, as assessed by the change in EEL area from survival to sacrifice, was increased 
in cEATx swine, compared to shams (p < 0.05). D) Graphical representation of the EEL/
Plaque area slope. Outward remodeling is reduced with CAD progression in sham-operated 
swine (p < 0.05), but is preserved following cEATx (p = 0.4).
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Figure 6. Removal of coronary epicardial adipose tissue results in significant outward 
remodeling and increases lumen diameter
A) cEATx animals experienced an expansion in lumen size following surgery (p < 0.05). 
This expansion was not observed in sham-operated animals (p = 0.4). B) During normal 
(sham) CAD progression, plaque area increased with little change in EEL area, resulting in 
increased coronary stenosis. C) Following cEAT removal, significant outward remodeling is 
observed as an increase in EEL area. This, combined with inhibition of increases in plaque 
size, results in an increased lumen area, thus reducing percent stenosis.
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Table 1
Metabolic Characteristics of Ossabaw Swine
Sham (n=5) cEATx (n=7) P-value
Body Weight (kg)
Survival Surgery 93.12 ± 1.36 88.09 ± 2.12 0.10
Sacrifice 110.14 ± 1.94 105.07 ± 3.30 0.26
Progression 17.02* 16.99* 0.99
Total Cholesterol (mg/dL)
Survival 471.80 ± 65.97 526.00 ± 56.71 0.55
Sacrifice 371.80 ± 79.41 533.00 ± 94.78 0.25
Progression
−100.00* 7.00 0.10
Triglycerides (mg/dL) Survival 36.20 ± 7.21 38.57 ± 6.83 0.82
Sacrifice 55.20 ± 5.52 58.14 ± 7.35 0.77
Progression 19.00 19.57 0.96
Fasting Glucose (mg/dL) Survival 79.74 ± 2.28 82.82 ± 2.66 0.42
Systolic Blood Pressure (mmHg) Survival 155.94 ± 5.18 157.70 ± 3.49 0.77
Diastolic Blood Pressure (mmHg) Survival 86.89 ± 4.27 82.74 ± 2.62 0.40
*
Indicates significant progression from survival to sacrifice, p < 0.05.
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